These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 17646279

  • 1. Human CYP2A6 is induced by estrogen via estrogen receptor.
    Higashi E, Fukami T, Itoh M, Kyo S, Inoue M, Yokoi T, Nakajima M.
    Drug Metab Dispos; 2007 Oct; 35(10):1935-41. PubMed ID: 17646279
    [Abstract] [Full Text] [Related]

  • 2. Human CYP1B1 is regulated by estradiol via estrogen receptor.
    Tsuchiya Y, Nakajima M, Kyo S, Kanaya T, Inoue M, Yokoi T.
    Cancer Res; 2004 May 01; 64(9):3119-25. PubMed ID: 15126349
    [Abstract] [Full Text] [Related]

  • 3. Dexamethasone-mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4 alpha to the proximal promoter.
    Onica T, Nichols K, Larin M, Ng L, Maslen A, Dvorak Z, Pascussi JM, Vilarem MJ, Maurel P, Kirby GM.
    Mol Pharmacol; 2008 Feb 01; 73(2):451-60. PubMed ID: 17978169
    [Abstract] [Full Text] [Related]

  • 4. Induction of human CYP2A6 is mediated by the pregnane X receptor with peroxisome proliferator-activated receptor-gamma coactivator 1alpha.
    Itoh M, Nakajima M, Higashi E, Yoshida R, Nagata K, Yamazoe Y, Yokoi T.
    J Pharmacol Exp Ther; 2006 Nov 01; 319(2):693-702. PubMed ID: 16857725
    [Abstract] [Full Text] [Related]

  • 5. Regulation of CYP2C19 expression by estrogen receptor α: implications for estrogen-dependent inhibition of drug metabolism.
    Mwinyi J, Cavaco I, Pedersen RS, Persson A, Burkhardt S, Mkrtchian S, Ingelman-Sundberg M.
    Mol Pharmacol; 2010 Nov 01; 78(5):886-94. PubMed ID: 20675569
    [Abstract] [Full Text] [Related]

  • 6. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 7. The ligands of estrogen receptor α regulate cytochrome P4502C9 (CYP2C9) expression.
    Mwinyi J, Cavaco I, Yurdakok B, Mkrtchian S, Ingelman-Sundberg M.
    J Pharmacol Exp Ther; 2011 Jul 01; 338(1):302-9. PubMed ID: 21493749
    [Abstract] [Full Text] [Related]

  • 8. 3'-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression.
    Wang J, Pitarque M, Ingelman-Sundberg M.
    Biochem Biophys Res Commun; 2006 Feb 10; 340(2):491-7. PubMed ID: 16378601
    [Abstract] [Full Text] [Related]

  • 9. Transcriptional regulation of the human CYP2A6 gene.
    Pitarque M, Rodríguez-Antona C, Oscarson M, Ingelman-Sundberg M.
    J Pharmacol Exp Ther; 2005 May 10; 313(2):814-22. PubMed ID: 15671201
    [Abstract] [Full Text] [Related]

  • 10. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
    Wihlén B, Ahmed S, Inzunza J, Matthews J.
    Mol Cancer Res; 2009 Jun 10; 7(6):977-86. PubMed ID: 19470599
    [Abstract] [Full Text] [Related]

  • 11. Human CYP2A6 is regulated by nuclear factor-erythroid 2 related factor 2.
    Yokota S, Higashi E, Fukami T, Yokoi T, Nakajima M.
    Biochem Pharmacol; 2011 Jan 15; 81(2):289-94. PubMed ID: 20887713
    [Abstract] [Full Text] [Related]

  • 12. Regulation of the Cyp2a5 gene involves an aryl hydrocarbon receptor-dependent pathway.
    Arpiainen S, Raffalli-Mathieu F, Lang MA, Pelkonen O, Hakkola J.
    Mol Pharmacol; 2005 Apr 15; 67(4):1325-33. PubMed ID: 15657367
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity.
    Pitarque M, von Richter O, Rodríguez-Antona C, Wang J, Oscarson M, Ingelman-Sundberg M.
    Hum Mutat; 2004 Mar 15; 23(3):258-66. PubMed ID: 14974084
    [Abstract] [Full Text] [Related]

  • 15. Effects of polymorphism in promoter region of human CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro.
    Yoshida R, Nakajima M, Nishimura K, Tokudome S, Kwon JT, Yokoi T.
    Clin Pharmacol Ther; 2003 Jul 15; 74(1):69-76. PubMed ID: 12844137
    [Abstract] [Full Text] [Related]

  • 16. Regulation of CYP2A5 gene by the transcription factor nuclear factor (erythroid-derived 2)-like 2.
    Abu-Bakar A, Lämsä V, Arpiainen S, Moore MR, Lang MA, Hakkola J.
    Drug Metab Dispos; 2007 May 15; 35(5):787-94. PubMed ID: 17303623
    [Abstract] [Full Text] [Related]

  • 17. Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.
    Boggess JF, Zhou C, Bae-Jump VL, Gehrig PA, Whang YE.
    Gynecol Oncol; 2006 Nov 15; 103(2):417-24. PubMed ID: 16690106
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen.
    Zhang M, Yan JD, Zhang L, Wang Q, Lü SJ, Zhang J, Zhu TH.
    Chin Med J (Engl); 2005 Oct 05; 118(19):1629-36. PubMed ID: 16232348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.